Up Over 10% This Year, How High Can Cineplex Stock Rally?

With Cineplex stock seeing an improvement in box office numbers and on the verge of profitability, here’s how high it could rally in 2023.

| More on:

After Cineplex (TSX:CGX) stock struggled throughout the pandemic, and after falling by more than 40% through 2022, it finally looks like 2023 will be the year it can turn its business around.

So far, already year to date, the stock is up by more than 10%. Furthermore, Cineplex stock is up 17% since mid-March, when it reported its strong box office numbers for February.

One of the biggest obstacles it has faced in the last few months is that even without capacity restrictions, a lack of compelling content as Hollywood plays catch-up from its pandemic shutdowns has hindered Cineplex stock from recovering sooner.

However, the box office numbers are now showing that as more blockbuster films get released, Cineplex has the potential to see a significant recovery in profitability this year, which could lead to a major rally.

In both January and February this year, box office numbers were roughly 88% of 2019 levels, representing a strong start to 2023. Furthermore, as the year goes on, more movies are set to be released.

By my count, there are more than 20 blockbuster movies scheduled to be released this year, including five superhero movies, several sequels of popular films, as well as highly anticipated movies such as Barbie.

Therefore, not only are pandemic restrictions not impacting Cineplex anymore, but Hollywood has also now clearly recovered from production shutdowns.

And as that leads to a recovery in attendance, it should have a significant influence on Cineplex’s ability to see its revenue recover and, most importantly, start becoming profitable again.

With Cineplex stock on the verge of profitability, it could rally significantly in 2023

As I mentioned above, 2022 saw many pandemic restrictions lifted, which led to a nearly 100% year-over-year increase in Cineplex stock’s revenue to just shy of $1.3 billion. Furthermore, it lost just $0.10 per share in 2022, compared to a loss of $4.46 per share in 2021 and $5.83 in 2020.

Plus, for 2023, analysts expect that not only will its revenue continue to rebound, to roughly $1.6 billion, but Cineplex should be able to generate earnings per share (EPS) of $0.50.

Therefore, the stock clearly has the potential for a consistent rally, especially when you consider how cheap it trades today.

How cheap is Cineplex today?

With the stock trading at less than $9 a share today, Cineplex has a forward price-to-earnings (P/E) ratio of less than 18 times. Furthermore, it’s trading at less than 8.9 times its expected 2024 earnings.

That’s not just undervalued; it’s also well below where Cineplex stock traded prior to the pandemic. For example, in 2019, it had an average P/E ratio of 26.4 times earnings.

Therefore, as long as there aren’t any unforeseen roadblocks that impact Cineplex’s operations throughout 2023, it has the potential to rally significantly.

To get to a P/E ratio of more than 26 times, Cineplex stock would have to rally to around $13 a share, roughly 45% higher than where it trades today. And it’s worth pointing out that right now, the average analyst target price is $12.76, shy of $13.

Furthermore, if Cineplex can see a noticeable improvement in its profitability and continue recovering through 2023, it could even rally past $13, considering that analysts expect it will earn $1.00 in EPS next year.

Therefore, by the end of 2023, even if Cineplex still only had a forward P/E ratio of 18 times as it does today, as long as analyst estimates remain the same, the stock could rally to roughly $18 a share, more than 100% higher than where it trades right now.

So if you have cash that you’re looking to invest and want to buy a high-potential stock that’s trading ultra-cheap, Cineplex is certainly one of the best companies to keep your eye on over the next few months.

Fool contributor Daniel Da Costa has no position in any of the stocks mentioned. The Motley Fool recommends Cineplex. The Motley Fool has a disclosure policy.

More on Investing

ETF is short for exchange traded fund, a popular investment choice for Canadians
Stock Market

3 Reasons VFV Is a Must-Buy for Long-Term Investors

Looking for a simple yet powerful way to grow your wealth over time? VFV might be the ETF your portfolio…

Read more »

Child measures his height on wall. He is growing taller.
Dividend Stocks

2 Dividend Stocks to Create Long-Term Family Wealth

Want dividends that can endure for decades? These two Canadian stocks offer steady cash and growing payouts.

Read more »

beyond meat burger with cheese
Dividend Stocks

Invest $7,000 in This Dividend Stock for $359 in Passive Income

Here’s how this iconic Canadian brand could help you earn over $350 in annual passive income with a simple one-time…

Read more »

Researcher works in hemp field
Cannabis Stocks

Forget Tilray and Buy This Cannabis Stock if the U.S. Reclassifies Marijuana in 2026

While Tilray stock gained over 40% on Friday, this cannabis company is a better buy if the U.S. reclassifies marijuana…

Read more »

GettyImages-1394663007
Stocks for Beginners

This Recession-Resistant TSX Stock Can Last for a Lifetime in a TFSA

TD Bank’s steady, recession-ready business could turn your TFSA into reliable, tax-free income for decades.

Read more »

Paper Canadian currency of various denominations
Dividend Stocks

1 Marvellous Dividend Stock Down 5% to Buy and Hold Forever

A small dip in Fortis could be your chance to lock in a 50-year dividend grower before utilities rebound.

Read more »

Pile of Canadian dollar bills in various denominations
Dividend Stocks

3 Dividend Stocks to Buy Now for Less Than $50 

Investing $50 weekly can transform your financial future. Find out how to make the most of your investment strategy.

Read more »

A cannabis plant grows.
Cannabis Stocks

Aurora Cannabis Surged 21% on Possible Cannabis Reclassification in the U.S. Is ACB Stock Finally a Good Buy?

Down almost 99% from all-time highs, Aurora Cannabis is a beaten-down marijuana stock that offers upside potential in December 2025.

Read more »